Figure 1: Schematic overview of search results |
Symbols represent the mean value per alcohol category. The solid line represents the men and the dotted line the women. Figure 2: The sigmoidal dose response model for cancer risk of the 20 most common cancers in the western world per gender associated with alcohol consumption |
Cancer type |
Age standardized rate per 100,000 men |
Percentage contribution in men |
Age standardized rate per 100,000 women |
Percentage contribution in women |
||||
1 |
Breast cancer* |
0 |
0 |
106.6 |
39.2 |
|||
2 |
Prostate cancer* |
105.5 |
26.8 |
- |
- |
|||
3 |
Colorectal cancer* |
59 |
15.0 |
36.1 |
13.3 |
|||
4 |
Lung cancer* |
66.3 |
16.8 |
26.1 |
9.6 |
|||
5 |
Bladder cancer* |
29.1 |
7.4 |
6.1 |
2.2 |
|||
6 |
Renal cancer |
17.4 |
4.4 |
8 |
2.4 |
|||
7 |
Gastric cancer |
15.2 |
3.9 |
7.1 |
2.6 |
|||
8 |
Ovarian cancer* |
- |
- |
12.6 |
4.6 |
|||
9 |
Non Hodgkin lymphoma |
13.8 |
3.5 |
9.6 |
3.5 |
|||
10 |
Skin cancer |
13.2 |
3.4 |
13.1 |
4.8 |
|||
11 |
Pancreatic cancer |
12.2 |
3.1 |
9 |
3.3 |
|||
12 |
Leukemia |
11.8 |
3.0 |
7.1 |
2.6 |
|||
13 |
Liver cancer |
11.1 |
2.8 |
3.6 |
1.3 |
|||
14 |
Esophageal cancer* |
8.4 |
2.1 |
2 |
0.7 |
|||
15 |
Larynx cancer* |
8.3 |
2.1 |
0.9 |
0.3 |
|||
16 |
Glioma, brain cancer |
8.1 |
2.1 |
5.9 |
2.2 |
|||
17 |
Multiple myeloma |
5.5 |
1.4 |
3.7 |
1.4 |
|||
18 |
Gall bladder cancer |
2.8 |
0.7 |
3.1 |
1.1 |
|||
19 |
Thyroid cancer |
3.5 |
0.9 |
9.3 |
3.4 |
|||
20 |
Hodgkin lymphoma |
2.6 |
0.7 |
2.1 |
0.8 |
|||
|
Total |
393.8 |
100.1 |
272 |
99.3 |
|||
Table 1: Incidence of twenty most common cancer types possibly associated with alcohol drinking in men and women of the European Union∧ |
Relative Risk for Men |
Relative Risk for Women |
||||||||||
Alcohol (g/day) |
0-2.5 |
2.5-14.9 |
15-29.9 |
30-60 |
>60 |
0-2.5 |
2.5-14.9 |
15-29.9 |
30-60 |
>60 |
|
Cancer type |
|||||||||||
1 |
Breast cancer(21) |
1 |
1 |
1 |
1 |
1 |
1 |
1.02 |
1.20 |
1.20 |
1.15 |
2 |
Prostate cancer(16) |
1 |
1.04 |
1.06 |
1.06 |
1.04 |
1 |
1 |
1 |
1 |
1 |
3 |
Colorectal cancer(36) |
1 |
1.06 |
1.13 |
1.27 |
1.35 |
1 |
1.06 |
1.13 |
1.27 |
1.35 |
4 |
Lung cancer(23) |
1 |
0.80 |
0.81 |
0.68 |
0.91 |
1 |
0.80 |
0.81 |
0.68 |
0.91 |
5 |
Bladder cancer(37) |
1 |
1 |
0.98 |
0.97 |
0.97 |
1 |
1 |
0.98 |
0.97 |
0.97 |
6 |
Renal cancer(38) |
1 |
0.85 |
0.73 |
0.66 |
0.60 |
1 |
0.85 |
0.68 |
0.54 |
0.54 |
7 |
Gastric cancer(39) |
1 |
1.03 |
1.13 |
1.17 |
1.12 |
1 |
1.03 |
1.13 |
1.17 |
1.12 |
8 |
Ovarian cancer(40) |
1 |
1 |
1 |
1 |
1 |
1 |
1.02 |
1.18 |
1.13 |
1.13 |
9 |
Non-Hodgkin lymphoma(41) |
1 |
0.88 |
0.87 |
0.87 |
0.84 |
1 |
0.88 |
0.87 |
0.87 |
0.84 |
10 |
Skin cancer(42) |
1 |
1.11 |
1.25 |
1.55 |
1.55 |
1 |
1.11 |
1.25 |
1.55 |
1.55 |
11 |
Pancreatic cancer(43) |
1 |
0.98 |
0.93 |
1.18 |
1.18 |
1 |
0.97 |
0.93 |
1.07 |
1.07 |
12 |
Leukemia(44) |
1 |
0.88 |
0.90 |
0.97 |
0.97 |
1 |
0.88 |
0.90 |
0.97 |
0.97 |
13 |
Liver cancer(16) |
1 |
1.05 |
1.08 |
1.08 |
1.59 |
1 |
0.81 |
1.24 |
1.24 |
3.89 |
14 |
Esophageal cancer(45) |
1 |
1.17 |
2.34 |
2.34 |
5.73 |
1 |
1.17 |
2.34 |
2.34 |
5.73 |
15 |
Larynx cancer(46) |
1 |
0.88 |
1.47 |
1.47 |
2.62 |
1 |
0.88 |
1.47 |
1.47 |
2.62 |
16 |
Glioma, brain cancer(47, 48) |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
17 |
Multiple myeloma(49) |
1 |
0.96 |
0.89 |
0.85 |
0.98 |
1 |
0.96 |
0.89 |
0.85 |
0.98 |
18 |
Gall bladder cancer |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
19 |
Thyroid cancer(50) |
1 |
0.83 |
0.75 |
0.80 |
0.80 |
1 |
0.80 |
0.73 |
0.71 |
0.80 |
20 |
Hodgkin lymphoma(51) |
1 |
0.71 |
0.73 |
0.73 |
0.74 |
1 |
0.71 |
0.73 |
0.73 |
0.74 |
Table 2: Relative risks for twenty cancer types reported to be possibly associated with alcohol drinking in the Western world in both men and women per alcohol consumption |
Risk contribution for men |
Risk contribution for women |
||||||||||||
Alcohol (g/day) | 0-2.5 |
2.5-14.9 |
15-29.9 |
30-60 |
>60 |
0-2.5 |
2.5-14.9 |
15-29.9 |
30-60 |
>60 |
|||
Cancer type |
Contr* |
Contr* |
|||||||||||
1 |
Breast cancer |
0 |
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
39.2 |
0.392 |
0.400 |
0.470 |
0.470 |
0.451 |
2 |
Prostate cancer |
26.8 |
0.268 |
0.279 |
0.284 |
0.284 |
0.279 |
0 |
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
3 |
Colorectal cancer |
15.0 |
0.150 |
0.159 |
0.170 |
0.191 |
0.203 |
13.3 |
0.133 |
0.141 |
0.150 |
0.169 |
0.180 |
4 |
Lung cancer |
16.8 |
0.168 |
0.134 |
0.136 |
0.114 |
0.153 |
9.6 |
0.096 |
0.077 |
0.078 |
0.065 |
0.087 |
5 |
Bladder cancer |
7.4 |
0.074 |
0.074 |
0.073 |
0.072 |
0.072 |
2.2 |
0.022 |
0.022 |
0.022 |
0.021 |
0.021 |
6 |
Renal cancer |
4.4 |
0.044 |
0.037 |
0.032 |
0.029 |
0.026 |
2.4 |
0.024 |
0.020 |
0.016 |
0.013 |
0.013 |
7 |
Gastric cancer |
3.9 |
0.039 |
0.042 |
0.044 |
0.046 |
0.047 |
2.6 |
0.026 |
0.028 |
0.029 |
0.031 |
0.031 |
8 |
Ovarian cancer |
0 |
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
4.6 |
0.046 |
0.047 |
0.054 |
0.052 |
0.052 |
9 |
Non Hodgkin lymphoma |
3.5 |
0.035 |
0.031 |
0.030 |
0.030 |
0.029 |
3.5 |
0.035 |
0.031 |
0.030 |
0.030 |
0.029 |
10 |
Skin cancer |
3.4 |
0.034 |
0.038 |
0.043 |
0.053 |
0.053 |
4.8 |
0.048 |
0.053 |
0.060 |
0.074 |
0.074 |
11 |
Pancreatic cancer |
3.1 |
0.031 |
0.030 |
0.029 |
0.037 |
0.037 |
3.3 |
0.033 |
0.032 |
0.031 |
0.035 |
0.035 |
12 |
Leukemia |
3.0 |
0.030 |
0.026 |
0.027 |
0.029 |
0.029 |
2.6 |
0.026 |
0.023 |
0.023 |
0.025 |
0.025 |
13 |
Liver cancer |
2.8 |
0.028 |
0.029 |
0.030 |
0.030 |
0.045 |
1.3 |
0.013 |
0.011 |
0.016 |
0.016 |
0.051 |
14 |
Esophageal cancer |
2.1 |
0.021 |
0.025 |
0.049 |
0.049 |
0.120 |
0.7 |
0.007 |
0.008 |
0.016 |
0.016 |
0.040 |
15 |
Larynx cancer |
2.1 |
0.021 |
0.018 |
0.031 |
0.031 |
0.055 |
0.3 |
0.003 |
0.003 |
0.004 |
0.004 |
0.008 |
16 |
Glioma, brain cancer |
2.1 |
0.021 |
0.021 |
0.021 |
0.021 |
0.021 |
2.2 |
0.022 |
0.022 |
0.022 |
0.022 |
0.022 |
17 |
Multiple Myeloma |
1.4 |
0.014 |
0.013 |
0.012 |
0.012 |
0.014 |
1.4 |
0.014 |
0.013 |
0.012 |
0.012 |
0.014 |
18 |
Gall bladder cancer |
0.7 |
0.007 |
0.007 |
0.007 |
0.007 |
0.007 |
1.1 |
0.011 |
0.011 |
0.011 |
0.011 |
0.011 |
19 |
Thyroid cancer |
0.9 |
0.009 |
0.007 |
0.007 |
0.007 |
0.007 |
3.4 |
0.034 |
0.027 |
0.025 |
0.024 |
0.027 |
20 |
Hodgkin lymphoma |
0.7 |
0.007 |
0.005 |
0.005 |
0.005 |
0.005 |
0.8 |
0.008 |
0.006 |
0.006 |
0.006 |
0.006 |
|
Total |
100.1 |
1.001 |
0.977 |
1.029 |
1.047 |
1.200 |
99.3 |
0.993 |
0.974 |
1.077 |
1.100 |
1.177 |
*Contribution to total cancer risk |
Men |
Women |
|||||||
Cancer type |
Direction* |
logEC50 |
R2 |
logEC50 |
R2 |
|||
1 |
Breast cancer |
up |
--- |
--- |
9.6 |
0.97 |
||
2 |
Prostate cancer |
up |
8.2 |
0.90 |
--- |
--- |
||
3 |
Colorectal cancer |
up |
22.8 |
0.94 |
22.8 |
0.94 |
||
4 |
Lung cancer |
down |
N.A.+ |
N.A.+ |
N.A.+ |
N.A.+ |
||
5 |
Bladder cancer |
down |
22.5 |
1.00 |
33.8 |
1.00 |
||
6 |
Renal cancer |
down |
8.7 |
0.92 |
22.4 |
0.90 |
||
7 |
Gastric cancer |
up |
21.9 |
0.93 |
9.1 |
0.94 |
||
8 |
Ovarian cancer |
up |
--- |
--- |
9.5 |
0.95 |
||
9 |
Non-Hodgkin lymphoma |
down |
8.2 |
0.97 |
8.2 |
0.97 |
||
10 |
Skin cancer |
up |
22.7 |
0.97 |
22.7 |
0.98 |
||
11 |
Pancreas cancer |
up |
37.3 |
0.97 |
37.4 |
0.84 |
||
12 |
Leukemia |
down |
N.A.+ |
N.A.+ |
N.A.+ |
N.A.+ |
||
13 |
Liver cancer |
up |
52.7 |
0.96 |
54.4 |
0.95 |
||
14 |
Esophageal cancer |
up |
45.6 |
0.93 |
45.6 |
0.93 |
||
15 |
Larynx cancer |
up |
45.5 |
0.89 |
45.8 |
0.96 |
||
16 |
Glioma, brain cancer |
absent& |
N.A.+ |
N.A.+ |
N.A.+ |
N.A.+ |
||
17 |
Multiple myeloma |
down |
N.A.+ |
N.A.+ |
N.A.+ |
N.A.+ |
||
18 |
Gall bladder cancer |
absent& |
N.A.+ |
N.A.+ |
N.A.+ |
N.A.+ |
||
19 |
Thyroid cancer |
down |
2.9 |
N.A. |
8.1 |
0.92 |
||
20 |
Hodgkin lymphoma |
down |
2.9 |
1.00 |
2.9 |
1.00 |
||
|
Overall |
up |
45.5 |
0.95 |
22.3 |
0.87 |
||
Table 4: The sigmoidal dose response model (Hill equation) parameters for the twenty most common cancer types and overall cancer risk |